Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Research and Insights

Biotechnology

Equities

Meet The Managers - Q&A with Chris Eccles and Catherine Tennyson
  • by Chris Eccles, Catherine Tennyson
  • 08 April 2024 (5 min read)
Future Trends

Game-changing Alzheimer’s drugs could drive a wave of investment across biotech
  • by Linden Thomson
  • 14 September 2023 (7 min read)
Technology

How DNA changed the world of medicine and drives investment opportunities today
  • by Linden Thomson
  • 25 April 2023 (7 min read)
Equities

Meet the Manager: Q&A with Cinney Zhang
  • by Cinney Zhang
  • 08 March 2023 (5 min read)
Equities

Genetics: transforming medicine
  • by AXA Investment Managers
  • 24 November 2021 (5 min read)
Demographics

Biotech and the battle to beat COVID-19
  • by AXA Investment Managers
  • 11 November 2020 (5 min read)
Technology

COVID-19 Impact: AXA IM’s macroeconomic and investment strategy update – biotechnology and healthcare special
  • by AXA Investment Managers
  • 01 May 2020 (10 min read)

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested.